Duggan Amends Pulse Biosciences Stake

TL;DR

Duggan filed an update on his Pulse Biosciences stake. Keep an eye on this.

AI Summary

Robert W. Duggan has amended his Schedule 13D filing for Pulse Biosciences, Inc. on July 8, 2024. The filing indicates a change in beneficial ownership, though specific new holdings or changes in percentage are not detailed in this excerpt. Duggan is a significant shareholder and his actions are closely watched by investors.

Why It Matters

Changes in beneficial ownership filings by significant shareholders like Robert W. Duggan can signal shifts in confidence or strategy, potentially impacting the stock price of Pulse Biosciences, Inc.

Risk Assessment

Risk Level: medium — Amendments to 13D filings by significant shareholders can indicate potential changes in control or strategy, warranting investor attention.

Key Players & Entities

• Robert W. Duggan (person) — Filing party and significant shareholder
• Pulse Biosciences, Inc. (company) — Subject company
• Adam W. Finerman, Esq. (person) — Authorized to receive notices
• Baker Hostetler LLP (company) — Legal counsel

FAQ

Key Financial Figures

• $0.001 — ame of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti
• $330,789,231 — directly by Mr. Duggan is approximately $330,789,231, including brokerage commissions. Such
• $5,162,096 — y owned by Mr. Duggan, is approximately $5,162,096, including brokerage commissions. Such
• $3,741,835 — y owned by Mr. Duggan, is approximately $3,741,835, including brokerage commissions. Such
• $10.00 — the “Units”), at a price of $10.00 per Unit. Each Unit consisted of one sh
• $11.00 — dquo;). Each warrant is exercisable for $11.00 per whole share, and is exercisable imm
• $16.50 — uer’s stock trading price exceeds $16.50 for twenty consecutive trading days and
• $22.00 — suer if its stock trading price exceeds $22.00 for twenty consecutive trading days. Mr

Filing Documents

• tm2419035d1_sc13da.htm (SC 13D/A) — 142KB
• 0001104659-24-078287.txt ( ) — 144KB

Identity and Background

Item 2. Identity and Background .

is hereby amended and restated to read

Item 2 is hereby amended and restated to read as follows: (a) This statement is filed by Robert W. Duggan (“Mr. Duggan”), Genius 24C Inc, a Florida corporation (“Genius”), and Blazon Corporation, a California corporation (“Blazon”). Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” Mr. Duggan is the sole shareholder and director of Genius and the majority shareholder of Blazon. By virtue of this relationship, Mr. Duggan may be deemed to beneficially own Shares owned by each of Genius and Blazon. Accordingly, the Reporting Persons are filing a joint Schedule 13D. (b) The principal business address of Mr. Duggan is 3957 Point Eden Way Hayward, California 94545. The principal business address of Genius is 616 Druid Road East, Clearwater, Florida 33756. The principal business address of Blazon is 6300 Wilshire Blvd, Ste 3020, Los Angeles, California 90048. (c) The principal occupation of Mr. Duggan is serving as a private investor. The principal business of Genius is education and training. The principal business of Blazon is investments. (d) The Reporting Persons have not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) The Reporting Persons have not, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. (f) Mr. Duggan is a citizen of the United States of America. Genius in a Florida corporation. Blazon is a California corporation. Item 3. Source and Amount of Funds or Other Consideration .

is hereby amended and

Item 3 is hereby amended and restated to read as follows: The aggregate purchase cost of the 42,172,003 Shares owned directly by Mr. Duggan is approximately $330,789,231, including brokerage commissions. Such Shares were acquired with personal funds. Mr. Duggan received his 183,100 stock options in connection with his service on the board of directors of the Issuer. The aggregate purchase cost of the 561,089 Shares owned by Genius 24C Inc d/b/a Genius Inc (“Genius”), which Mr. Duggan is the sole shareholder of and may be deemed to be beneficially owned by Mr. Duggan, is approximately $5,162,096, including brokerage commissions. Such Shares were acquired with working capital. The aggregate purchase cost of the 400,877 Shares owned by Blazon Corporation, which Mr. Duggan is the majority shareholder of and may be deemed to be beneficially owned by Mr. Duggan, is approximately $3,741,835, including brokerage commissions. Such Shares were acquired with working capital. Item 4. Purpose of Transaction .

is hereby amended to

Item 4 is hereby amended to add the following: On July 3, 2024, the Issuer closed its rights offering (the “Offering”) for the sale of 5,999,999 units (the “Units”), at a price of $10.00 per Unit. Each Unit consisted of one share of the Issuer’s common stock, and two warrants, each being a warrant to purchase one-half of one share of common stock (together, the “Warrants”). Each warrant is exercisable for $11.00 per whole share, and is exercisable immediately and will expire on the fifth anniversary of the closing of the rights offering. Half of the Warrants issued in the rights offering are redeemable by the Issuer if the Issuer’s stock trading price exceeds $16.50 for twenty consecutive trading days and the other half of the Warrants issued in the rights offering are redeemable by the Issuer if its stock trading price exceeds $22.00 for twenty consecutive trading days. Mr. Duggan acquired an aggregate of 5,187,824 Units following the exercise of his basic and over-subscription privileges in connection with the Offering. Genius and Blazon Corporation acquired an aggregate of 69,020 Units and 49,312 Units, respectively, following the exercise of its basic and over-subscription privileges in connection with the Offering. Item 5. Interest in Securities of the Issuer . Items 5(a)-(c) are hereby amended to read as follows: The aggregate percentage of Shares reported owned by each person named herein is based upon 61,228,333 Shares outstanding, which is the total number of Shares outstanding as of July 3, 2024, as reported by the Issuer in connection with the closing of the Offering. A. Genius 24C Inc d/b/a Genius Inc a) As of the close of business on July 3, 2024, Genius beneficially owned 630,109 Shares. Percentage: Approximately 1.0% b) 1. Sole power to vote or direct vote: 630,109 2. Shared power to vote or direct vote: 0 3. Sole power to dispose or direct the disposition: 630,109 4. Shared power to d

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: July 8, 2024 GENIUS 24C INC By: /s/ Martin Bittner Name: Martin Bittner Title: Chief Operating Officer BLAZON CORPORATION By: /s/ Robert W. Duggan Name: Robert W. Duggan Title: Authorized Signatory /s/ Robert W. Duggan Robert W. Duggan

View Full Filing

View this SC 13D/A filing on SEC EDGAR